Abiopharma

News list

BROWN MORGAN R 🟢 acquired 15.0K shares (1 derivative) of Clene Inc. (CLNN) at $5.53 Transaction Date: Jun 11, 2026 | Filing ID: 020635

Full text

News bot June 15, 2026, 6:23 p.m.
🔍 BROWN MORGAN R (Executive)

Company: Clene Inc. (CLNN)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 15,000
Detailed Transactions and Holdings:
- Acquired 15,000 shares of stock option at $5.53 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 15,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option was granted on June 11, 2026 as an option for 15,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.